According to the 'multiple‐hit'hypothesis, several factors can act simultaneously in
nonalcoholic fatty liver disease (NAFLD) progression. Increased nitro‐oxidative (nitroso …

Abstract Introduction Resveratrol (3, 5, 4'-trihydroxy-trans-stilbene) is a polyphenol obtained
from diverse groups of plants, especially in the muscadine grape, red wine, lingonberry …

Nonalcoholic fatty liver disease (NAFLD) includes a broad spectrum of liver dysfunctions
and it is predicted to become the primary cause of liver failure and hepatocellular carcinoma …

Abstract Non-Alcoholic Fatty Liver Disease (NAFLD) is a common condition affecting around
10–25% of the general adult population, 15% of children, and even> 50% of individuals who …

Many studies have shown that resveratrol has a lot of therapeutic effects on liver disorders.
Its administration can significantly increase the survival rate after liver transplantation …

Nonalcoholic fatty liver disease (NAFLD) defines fat accumulation in the liver, and it is
commonly associated with metabolic syndromes like diabetes and obesity. Progressive …

Resveratrol has long been proposed as being beneficial to human health across multiple
morbidities, yet there is currently no conclusive clinical evidence to advocate its …

Ethanol consumption triggers oxidative stress by generating reactive oxygen species (ROS)
through its metabolites. This process leads to steatosis and liver inflammation, which are …

Non-alcoholic fatty liver disease (NAFLD) is now the most common cause of chronic liver
disease, worldwide. The molecular pathogenesis of NAFLD is complex, involving numerous …

Nonalcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease
worldwide, ranging from liver steatosis to nonalcoholic steatohepatitis, which ultimately …